Literature DB >> 15774510

Uterine blood flow responses to ICI 182 780 in ovariectomized oestradiol-17beta-treated, intact follicular and pregnant sheep.

Ronald R Magness1, Terrance M Phernetton, Tiffini C Gibson, Dong-Bao Chen.   

Abstract

Oestrogen dramatically increases uterine blood flow (UBF) in ovariectomized (Ovx) ewes. Both the follicular phase and pregnancy are normal physiological states with elevated levels of circulating oestrogen. ICI 182 780 is a pure steroidal oestrogen receptor (ER) antagonist that blocks oestrogenic actions in oestrogen-responsive tissue. We hypothesized that an ER-mediated mechanism is responsible for in vivo rises in UBF in physiological states of high oestrogen. The purpose of the study was to examine the effect of an ER antagonist on exogenous and endogenous oestradiol-17beta (E2beta)-mediated elevations in UBF. Sheep were surgically instrumented with bilateral uterine artery blood flow transducers, and uterine and femoral artery catheters. Ovx animals (n = 8) were infused with vehicle (35% ethanol) or ICI 182 780 (0.1-3.0 microg min(-1)) into one uterine artery for 10 min before and 50 min after E2beta was given (1 microg kg(-1) I.V. bolus) and UBF was recorded for an additional hour. Intact, cycling sheep were synchronized to the follicular phase using progesterone, prostaglandin F2alpha(PGF2alpha) and pregnant mare serum gonadotrophin (PMSG). When peri-ovulatory rises in UBF reached near peak levels, ICI 182 780 (1 or 2 microg (ml uterine blood flow)-1) was infused unilaterally (n = 4 sheep). Ewes in the last stages of pregnancy (late pregnant ewes) were also given ICI 182 780 (0.23-2.0 microg (ml uterine blood flow)-1; 60 min infusion) into one uterine artery (n = 8 sheep). In Ovx sheep, local infusion of ICI 182 780 did not alter systemic cardiovascular parameters, such as mean arterial blood pressure or heart rate; however, it maximally decreased ipsilateral, but not contralateral, UBF vasodilatory responses to exogenous E2beta by approximately 55-60% (P < 0.01). In two models of elevated endogenous E2beta, local ICI 182 780 infusion inhibited the elevated UBF seen in follicular phase and late pregnant ewes in a time-dependent manner by approximately 60% and 37%, respectively; ipsilateral >> contralateral effects (P < 0.01). In late pregnant sheep ICI 182 780 also mildly and acutely (for 5-30 min) elevated mean arterial pressure and heart rate (P < 0.05). We conclude that exogenous E2beta-induced increases in UBF in the Ovx animal and endogenous E2beta-mediated elevations of UBF during the follicular phase and late pregnancy are partially mediated by ER-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774510      PMCID: PMC1464500          DOI: 10.1113/jphysiol.2005.086439

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  68 in total

Review 1.  A pharmacological review of selective oestrogen receptor modulators.

Authors:  S R Goldstein; S Siddhanti; A V Ciaccia; L Plouffe
Journal:  Hum Reprod Update       Date:  2000 May-Jun       Impact factor: 15.610

2.  Coronary and uterine vascular responses to raloxifene in the sheep.

Authors:  W D Zoma; R S Baker; K E Clark
Journal:  Am J Obstet Gynecol       Date:  2000-03       Impact factor: 8.661

3.  Uterine blood flow in relation to endogenous hormones during estrous cycle and early pregnancy.

Authors:  H Roman-Ponce; D Caton; W W Thatcher; R Lehrer
Journal:  Am J Physiol       Date:  1983-12

4.  Steroid concentrations in uterine lymph and uterine arterial plasma of gilts during the estrous cycle and early pregnancy.

Authors:  R R Magness; S P Ford
Journal:  Biol Reprod       Date:  1982-11       Impact factor: 4.285

5.  Estrone, estradiol-17 beta and progesterone concentrations in uterine lymph and systemic blood throughout the porcine estrous cycle.

Authors:  R R Magness; S P Ford
Journal:  J Anim Sci       Date:  1983-08       Impact factor: 3.159

6.  Induction and inhibition of uterine vasodilation by catechol estrogen in oophorectomized, nonpregnant ewes.

Authors:  C R Rosenfeld; G M Jackson
Journal:  Endocrinology       Date:  1982-04       Impact factor: 4.736

7.  Calcium-activated potassium channels and nitric oxide coregulate estrogen-induced vasodilation.

Authors:  C R Rosenfeld; R E White; T Roy; B E Cox
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-07       Impact factor: 4.733

8.  Regulation of types I and III NOS in ovine uterine arteries by daily and acute estrogen exposure.

Authors:  W A Salhab; P W Shaul; B E Cox; C R Rosenfeld
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-06       Impact factor: 4.733

9.  Uterine vascular effects of estetrol in nonpregnant ewes.

Authors:  M G Levine; M Miodovnik; K E Clark
Journal:  Am J Obstet Gynecol       Date:  1984-03-15       Impact factor: 8.661

10.  Corticosteroid suppression of estrogen-induced uterine blood flow in nonpregnant sheep.

Authors:  A G Monheit; R Resnik
Journal:  Am J Obstet Gynecol       Date:  1981-02-15       Impact factor: 8.661

View more
  47 in total

1.  Ovine surgical model of uterine space restriction: interactive effects of uterine anomalies and multifetal gestations on fetal and placental growth.

Authors:  Katie M Meyer; Jill M Koch; Jayanth Ramadoss; Pamela J Kling; Ronald R Magness
Journal:  Biol Reprod       Date:  2010-06-23       Impact factor: 4.285

2.  2-D DIGE uterine endothelial proteomic profile for maternal chronic binge-like alcohol exposure.

Authors:  Jayanth Ramadoss; Ronald R Magness
Journal:  J Proteomics       Date:  2011-08-04       Impact factor: 4.044

3.  Chronic hypoxia during gestation causes epigenetic repression of the estrogen receptor-α gene in ovine uterine arteries via heightened promoter methylation.

Authors:  Chiranjib Dasgupta; Man Chen; Haitao Zhang; Shumei Yang; Lubo Zhang
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190

Review 4.  Estrogen receptor-α and estrogen receptor-β in the uterine vascular endothelium during pregnancy: functional implications for regulating uterine blood flow.

Authors:  Mayra B Pastore; Sheikh O Jobe; Jayanth Ramadoss; Ronald R Magness
Journal:  Semin Reprod Med       Date:  2012-01-23       Impact factor: 1.303

5.  Effects of L-glutamine supplementation on maternal and fetal hemodynamics in gestating ewes exposed to alcohol.

Authors:  Onkar B Sawant; Jayanth Ramadoss; Gary D Hankins; Guoyao Wu; Shannon E Washburn
Journal:  Amino Acids       Date:  2014-05-09       Impact factor: 3.520

6.  Convergent ERK1/2, p38 and JNK mitogen activated protein kinases (MAPKs) signalling mediate catecholoestradiol-induced proliferation of ovine uterine artery endothelial cells.

Authors:  Rosalina Villalon Landeros; Sheikh O Jobe; Gabrielle Aranda-Pino; Gladys E Lopez; Jing Zheng; Ronald R Magness
Journal:  J Physiol       Date:  2017-06-05       Impact factor: 5.182

7.  E2β stimulates ovine uterine artery endothelial cell H2S production in vitro by estrogen receptor-dependent upregulation of cystathionine β-synthase and cystathionine γ-lyase expression†.

Authors:  Thomas J Lechuga; Qian-Rong Qi; Theresa Kim; Ronald R Magness; Dong-Bao Chen
Journal:  Biol Reprod       Date:  2019-02-01       Impact factor: 4.285

8.  Estrogen Receptor-β Mediates Estradiol-Induced Pregnancy-Specific Uterine Artery Endothelial Cell Angiotensin Type-2 Receptor Expression.

Authors:  Jay S Mishra; Gigi M Te Riele; Qian-Rong Qi; Thomas J Lechuga; Kathirvel Gopalakrishnan; Dong-Bao Chen; Sathish Kumar
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

9.  Triclosan is a potent inhibitor of estradiol and estrone sulfonation in sheep placenta.

Authors:  Margaret O James; Wenjun Li; David P Summerlot; Laura Rowland-Faux; Charles E Wood
Journal:  Environ Int       Date:  2009-03-18       Impact factor: 9.621

10.  The effects of the ovarian cycle and pregnancy on uterine vascular impedance and uterine artery mechanics.

Authors:  Benjamin J Sprague; Terrance M Phernetton; Ronald R Magness; Naomi C Chesler
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-03-17       Impact factor: 2.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.